Dr. Kang-Mieler’s translational research projects focus on ocular drug delivery, retinal imaging and analysis (including AI and machine learning), biomarkers, retinal hemodynamics, and electrophysiology. Her clinical interests encompass retinal vascular diseases such as age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity.
Illinois Institute of Technology •
01/2019 – 01/2022 •
Biomedical Engineering
Illinois Institute of Technology •
01/2007 – 01/2019 •
Biomedical Engineering
University of Illinois at Chicago •
01/2001 – 01/2007 •
Ophthalmology and Visual Sciences
Illinois Institute of Technology •
01/2001 – 01/2007 •
Biomedical Engineering
University of Illinois at Chicago •
01/1999 – 01/2001 •
Ophthalmology and Visual Sciences
University of Illinois at Chicago •
01/1999 – 01/2001 •
Ophthalmology and Visual Sciences